Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1981 Jan;72(1):31–40. doi: 10.1111/j.1476-5381.1981.tb09101.x

Correlation between catecholamine secretion from bovine isolated chromaffin cells and [3H]-ouabain binding to plasma membranes

Dominique Aunis, Antonio G García
PMCID: PMC2071541  PMID: 6164427

Abstract

1 Secretion of catecholamines (CA) evoked by ouabain, chlormadinone acetate (CMA), phenoxybenzamine (Pbz) and vanadate, four agents known to inhibit Na+, K+-dependent Mg2+-activated adenosine triphosphatase (ATPase) activity has been studied in suspensions of bovine isolated adrenal medullary cells.

2 Acetylcholine (ACh) evoked a 5 fold increase of the basal CA secretion from isolated cells suspended in oxygenated Krebs-bicarbonate solution kept at 27°C. Secretion was antagonized by Ca2+-deprivation or hexamethonium, indicating good functional viability of the cells.

3 Ouabain (10-7 to 10-4 M) evoked a progressive, dose-dependent release of CA from cell suspensions. Study of the time course of the secretory response for 2 h allowed the separation of two components in the secretory response at all doses studied: a slow initial component (0.011 pg/min CA) and a second faster component (0.032 pg/min CA).

4 CMA evoked a clear-cut CA secretory response. The ED50 for CMA was 10-4 M, as compared to 3 × 10-6 M for ouabain. Pbz and vanadate did not induce CA release.

5 [3H]-ouabain was taken up and bound to intact isolated cells by a non-saturable binding process. However, in semi-purified plasma membranes from bovine adrenal medulla a saturable specific [3H]-ouabain binding process was observed with a KD of 8.1 nM. Binding to the membranes was ATP-dependent and antagonized by K+.

6 [3H]-ouabain specific binding to membranes was antagonized by ouabain and CMA, but not by Pbz or vanadate; the ID50 for ouabain and CMA were 10-6 and 10-5 M respectively.

7 Ouabain partially inhibited, in a dose-dependent manner, Na+, K+-Mg2+ ATPase activity of the semi-purified plasma membranes.

8 The results demonstrate a good correlation between the ability of different drugs, known to inhibit ATPase activity, to displace [3H]-ouabain binding to adreno—medullary plasma membranes and their capacity to evoke a CA secretory response from isolated chromaffin cells. The data also suggest that the CA secretory effects of ouabain may not be due simply to inhibition of the Na+ pump and the subsequent ionic redistribution across the plasma membrane; a second mechanism may also be involved.

Full text

PDF
32

Images in this article

33Figure 1
on p.33

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTON A. H., SAYRE D. F. A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962 Dec;138:360–375. [PubMed] [Google Scholar]
  2. Akera T., Brody T. M. The role of Na+,K+-ATPase in the inotropic action of digitalis. Pharmacol Rev. 1977 Sep;29(3):187–220. [PubMed] [Google Scholar]
  3. Akera T. Membrane adenosinetriphosphatase: a digitalis receptor? Science. 1977 Nov 11;198(4317):569–574. doi: 10.1126/science.144320. [DOI] [PubMed] [Google Scholar]
  4. Baker P. F., Crawford A. C. A note of the mechanism by which inhibitors of the sodium pump accelerate spontaneous release of transmitter from motor nerve terminals. J Physiol. 1975 May;247(1):209–226. doi: 10.1113/jphysiol.1975.sp010928. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Banks P. The effect of ouabain on the secretion of catecholamines and on the intracellular concentration of potassium. J Physiol. 1967 Dec;193(3):631–637. doi: 10.1113/jphysiol.1967.sp008383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cantley L. C., Jr, Josephson L., Warner R., Yanagisawa M., Lechene C., Guidotti G. Vanadate is a potent (Na,K)-ATPase inhibitor found in ATP derived from muscle. J Biol Chem. 1977 Nov 10;252(21):7421–7423. [PubMed] [Google Scholar]
  7. Dixon W. R., Garcia A. G., Kirpekar S. M. Release of catecholamines and dopamine beta-hydroxylase from the perfused adrenal gland of the cat. J Physiol. 1975 Jan;244(3):805–824. doi: 10.1113/jphysiol.1975.sp010827. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Duncan C. J. The action of ouabain in promoting the release of catecholamines. Experientia. 1977 Jul 15;33(7):923–924. doi: 10.1007/BF01951283. [DOI] [PubMed] [Google Scholar]
  9. Erdmann E., Krawietz W., Phillipp G., Hackbarth I., Schmitz W., Scholz H. Stimulatory effect of vanadate on (Na+ + K+)-ATPase activity and on 3H-ouabain-binding in a cat heart cell membrane preparation. Nature. 1979 Mar 29;278(5703):459–461. doi: 10.1038/278459a0. [DOI] [PubMed] [Google Scholar]
  10. Fenwick E. M., Fajdiga P. B., Howe N. B., Livett B. G. Functional and morphological characterization of isolated bovine adrenal medullary cells. J Cell Biol. 1978 Jan;76(1):12–30. doi: 10.1083/jcb.76.1.12. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Garcia A. G., Kirpekar S. M. Letter: Inhibition of Na, K-activated ATPase and release of neurotransmitters. Nature. 1975 Oct 23;257(5528):722–722. doi: 10.1038/257722b0. [DOI] [PubMed] [Google Scholar]
  12. Garcia A. G., Kirpekar S. M. On the mechanism of release of norepinephrine from cat spleen slices by sodium deprivation and calcium pretreatment. J Pharmacol Exp Ther. 1975 Feb;192(2):343–350. [PubMed] [Google Scholar]
  13. Garcia A. G., Kirpekar S. M. Release of noradrenaline from the cat spleen by sodium deprivation. Br J Pharmacol. 1973 Apr;47(4):729–747. doi: 10.1111/j.1476-5381.1973.tb08200.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Ghysel-Burton J., Godfraind T. Stimulation and inhibition of the sodium pump by cardioactive steroids in relation to their binding sites and their inotropic effect on guinea-pig isolated atria. Br J Pharmacol. 1979 Jun;66(2):175–184. doi: 10.1111/j.1476-5381.1979.tb13662.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hexum T. D. Studies on the reaction catalyzed by transport (Na, K) adenosine triphosphatase-II. In vitro and in vivo effects of phenoxybenzamine. Biochem Pharmacol. 1978;27(17):2109–2114. doi: 10.1016/0006-2952(78)90281-2. [DOI] [PubMed] [Google Scholar]
  16. Kirpekar S. M., Prat J. C., Yamamoto H. Effects of metabolic inhibitors on norepinephrine release from the perfused spleen of the cat. J Pharmacol Exp Ther. 1970 Apr;172(2):342–350. [PubMed] [Google Scholar]
  17. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  18. LaBella F. S., Bihler I., Kim R. S. Progesterone derivative binds to cardiac ouabain receptor and shows dissociation between sodium pump inhibition and increased contractile force. Nature. 1979 Apr 5;278(5704):571–573. doi: 10.1038/278571a0. [DOI] [PubMed] [Google Scholar]
  19. Lindmar R., Löffelholz K. The neuronal efflux of noradrenaline: dependency on sodium and facilitation by ouabain. Naunyn Schmiedebergs Arch Pharmacol. 1974;284(1):93–100. doi: 10.1007/BF00499974. [DOI] [PubMed] [Google Scholar]
  20. Nakazato Y., Ohga A., Onoda Y. The effect of ouabain on noradrenaline output from peripheral adrenergic neurones of isolated guinea-pig vas deferens. J Physiol. 1978 May;278:45–54. doi: 10.1113/jphysiol.1978.sp012291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Naylor G. J., Dick D. A., Dick E. G., Le Poidevin D., Whyte S. F. Erythrocyte membrane cation carrier in depressive illness. Psychol Med. 1973 Nov;3(4):502–508. doi: 10.1017/s0033291700054313. [DOI] [PubMed] [Google Scholar]
  22. Vizi E. S. Na+-K+-activated adenosinetriphosphatase as a trigger in transmitter release. Neuroscience. 1978;3(4-5):367–384. doi: 10.1016/0306-4522(78)90040-4. [DOI] [PubMed] [Google Scholar]
  23. Wilson S. P., Kirshner N. Localization of adenylate cyclase in adrenal medulla. Mol Pharmacol. 1977 Mar;13(2):382–385. [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES